Patients feel benefit as drug prices cut

    By Wang Xiaodong | China Daily | Updated: 2020-01-14 04:07
    Share
    Share - WeChat
    Li Ziyu (right), an expert at the Beijing Cancer Hospital, explains treatment to a patient in Cangzhou, Hebei province, as part of cooperation between large hospitals in Beijing and smaller ones outside of the city. [Photo/Xinhua]

    Health: Reimbursement list widens

    The negotiations resulted in the average price of drugs being reduced by just over 60 percent, according to the health administration. Agreements were also renewed for another 27 drugs already on the list, with an average price cut of 26 percent, the administration said. The expanded list took effect on Jan 1.

    These drugs have proved effective in treating cancer and other serious illnesses, such as hepatitis, diabetes, tuberculosis, and both rare and cardiovascular diseases.

    Most of the drugs have only been on the market for just two years. Their inclusion on the reimbursement list will further reduce patients' financial burden, according to the administration.

    Xiong Xianjun, head of medical services supervision at the administration, said, "The negotiations were the largest of their kind in China in recent years, resulting in many achievements, including a significant fall in drug prices.

    "Some imported drugs will be sold at the lowest prices in the world on the Chinese mainland. Coupled with reimbursement by healthcare insurance funds, it is estimated that the price drop will reduce patients' spending more than 80 percent in general, and by over 95 percent in a few cases."

    Only a few years ago, many imported patented drugs, including those to treat cancer, cost more in China than in many other countries due to factors including higher tariffs, costs incurred by middlemen and a lack of domestic competitors. There was no price negotiation system, and many of the drugs were not included in the basic healthcare insurance program for reimbursement.

    This placed a great financial burden on millions of cancer patients, with many of them having to buy cheaper generic drugs from countries such as India through the internet, posing potential health and legal risks.

    Cancer cases and other chronic illnesses such as cardiovascular disease are rising. According to the National Cancer Institute, more than 10,000 people a day in China are diagnosed with cancer due to the aging population and unhealthy lifestyles. As a result, medical bills are expected to rise rapidly in the coming years.

    Last year, Dying to Survive, a movie based on real-life events centering on the dilemma facing many leukemia patients, sparked heated public debate, with calls being made for accelerated efforts to improve patients' access to expensive patented drugs.

    |<< Previous 1 2 3 4 Next   >>|
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    国产亚洲精品无码成人| 亚洲精品色午夜无码专区日韩| 精品久久亚洲中文无码| 亚洲国产av无码精品| 国产色爽免费无码视频| 一本大道香蕉中文在线高清 | 好硬~好爽~别进去~动态图, 69式真人无码视频免 | 永久免费无码网站在线观看个 | 国产成人亚洲综合无码| 波多野结衣AV无码久久一区| 最近中文字幕免费mv在线视频| 无码少妇一区二区浪潮av| 狠狠躁天天躁无码中文字幕| 亚洲精品无码午夜福利中文字幕 | 性无码免费一区二区三区在线| 天堂在线观看中文字幕| 亚洲乱码中文字幕综合| 中文字幕 qvod| 国产精品无码国模私拍视频 | 精品无码人妻一区二区三区 | 无码专区中文字幕无码| 无码人妻一区二区三区兔费| 超清无码熟妇人妻AV在线电影| 中文字幕一区二区三区永久| 一区二区三区在线观看中文字幕 | 日日摸夜夜爽无码毛片精选| 最新版天堂资源中文网| 日韩中文字幕欧美另类视频| 痴汉中文字幕视频一区| 欧美日韩中文字幕2020| 中文字幕在线观看日本| 中文字幕在线视频网| 亚洲国产午夜中文字幕精品黄网站| 久久99中文字幕久久| 最新版天堂资源中文网| 亚洲欧洲中文日韩久久AV乱码| 中文字幕在线观看亚洲| 无码人妻精品一区二区三区蜜桃| 国产又爽又黄无码无遮挡在线观看 | 国产成人无码精品久久久免费 | 日本妇人成熟免费中文字幕|